Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep;19(9):901-10.
doi: 10.1002/pds.1984.

Adverse drug events in the outpatient setting: an 11-year national analysis

Affiliations

Adverse drug events in the outpatient setting: an 11-year national analysis

Florence T Bourgeois et al. Pharmacoepidemiol Drug Saf. 2010 Sep.

Abstract

Purpose: Adverse drug events (ADEs) are a common complication of medical care resulting in high morbidity and medical expenditure. Population level estimates of outpatient ADEs are limited. Our objective was to provide national estimates and characterizations of outpatient ADEs and determine risk factors associated with these events.

Methods: Data are from the National Center for Health Statistics which collects information on patient visits to outpatient clinics and emergency departments throughout the United States. We examined visits between 1995 and 2005 and measured the national annual estimates of and risk factors for outpatient ADEs requiring medical treatment.

Results: The national annual number of ADE-related visits was 4 335,990 (95%CI: 4 326 872-4 345 108). Visits for ADEs to outpatient clinics increased over the study period from 9.0 to 17.0 per 1000 persons (p-value for trend < 0.001). In multivariate analyses, factors associated with ADE visits included patient age (OR: 2.13; 95%CI: 1.63-2.79 for 65 years and older), number of medications taken by patient (OR: 1.88; 95%CI: 1.58-2.25 for five medications or more), and female gender (OR: 1.51; 95%CI: 1.34-1.71). Overall, outpatient ADEs resulted in 107,468 (95%CI: 89 011-125 925) hospital admissions annually, with older patients at highest risk for hospitalization (p-value for trend < 0.001).

Conclusions: Both patient age and polypharmacy use are risk factors for ADE-related healthcare visits, which have substantially increased in outpatient clinics between 1995 and 2005. The incidence of ADEs has particularly increased among patients 65 years and older with as many as 1 in 20 persons seeking medical care for an ADE.

PubMed Disclaimer

Figures

Figure 1
Figure 1. National Incidence of Adverse Drug Events Treated in U.S. Outpatient Clinics and Emergency Departments, 1995–2005
A, Mean annual incidence of adverse drug event cases treated in outpatient clinics was 12.7 per 1000 persons (95% CI, 11.5– 14.2); P value for trend <0.001. Mean annual incidence of adverse drug event cases treated in emergency departments was 2.8 (95% CI, 2.6– 3.1) per 1000 persons; P value for trend =0.70. B, Mean annual incidence of adverse drug event cases treated in outpatient clinics and emergency departments was 13.2 per 1000 persons (95% CI, 11.5–14.9) between 1995 and 2000 and 18.1 per 1000 persons (95% CI, 15.6–20.5) between 2001 and 2005. P value for trend with increasing age was <0.001 during both time periods. Error bars indicate 95% confidence intervals.
Figure 2
Figure 2. National Proportions of Visits to U.S. Outpatient Clinics and Emergency Departments Associated with Three or More Medication Prescriptions, 1995–2005
Mean annual rate of outpatient visits associated with 3 to 4 medication prescriptions was 14.9% (95% CI, 14.6%– 15.2%) and with 5 or more medication prescriptions 9.4% (95% CI, 8.9%–9.8%). P value for trend was <0.001 both for use of 3 to 4 medications and use of 5 or more medications.

References

    1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. Jama. 1998;279(15):1200–1205. - PubMed
    1. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. Jama. 1995;274(1):29–34. - PubMed
    1. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. Jama. 1997;277(4):301–306. - PubMed
    1. Mjorndal T, Boman MD, Hagg S, et al. Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf. 2002;11(1):65–72. - PubMed
    1. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Bmj. 2004;329(7456):15–19. - PMC - PubMed

Publication types

MeSH terms